Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Tyler VanHunnik Injured in Crash on Highway 49


Car Rolls Down Embankment in Grass Valley Accident

Grass Valley, CA (March 25, 2020) – A man was injured in a rollover crash in Grass Valley. The accident occurred on the afternoon of March 25 on Highway 49.

Tyler VanHunnik, 22, of Grass Valley, was driving a Honda Accord on northbound Highway 49 when he lost control around a curve. He went up an embankment and his car rolled over several times. VanHunnik, who was not wearing a seat belt, was ejected from his car. He is currently hospitalized in critical condition.

#Grass Valley

#95945


March 12, 2020

1 Killed, 3 Injured in Crash on Blaker Road

Car Hits Tree in Fatal Ceres Accident...


October 10, 2019

Woman Killed in Crash at Chapala and W. Figueroa Streets

MTD Bus Hits Victim in Fatal Santa Barbara Accident Santa Barbara, CA (October ...


December 19, 2019

1 Killed in Crash on Oakdale Road

High-Speed Police Chase Leads to Fatal Modesto Accident ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.